| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
3 companies
Springer Timothy A is a Director, 10% Owner at Cartesian Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 23 buys and 0 sells.
Estimated insider holdings value: $240.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2020 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 3,644,692 | $2.62 | $9,555,907.22 | +10.1% | |
| Oct 20, 2020 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 1,887,696 | $2.30 | $4,336,229.62 | +6.7% | |
| Oct 9, 2020 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 276,703 | $2.00 | $552,465.21 | +3.2% | |
| Oct 8, 2020 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 3,185,394 | $1.71 | $5,445,212.68 | +15.1% | |
| Aug 14, 2019 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 10,000 | $1.74 | $17,415.00 | +13.1% | |
| Jan 25, 2019 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 4,071,418 | $1.51 | $6,142,904.81 | +863.8% | |
| May 29, 2018 | SRRK Scholar Rock Holding Corp | Director, 10% Owner | Buy | 71,428 | $14.00 | $999,992.00 | +2.2% | |
| Nov 14, 2017 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 57,598 | $9.27 | $534,094.73 | +14.3% | |
| Nov 10, 2017 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 53,338 | $9.19 | $490,437.17 | +3.5% | |
| Jun 27, 2017 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 338,791 | $17.71 | $5,999,988.61 | +2,038% |